LRRK2 and Parkinson disease: In other in-vitro study sed, GBA1-heterozygous-null iPSC-derived neurons instead of mutant GBA1 were used, and a decrease of glucocerebrosidase in DA neurons derived from LRRK2-PD patients with G2019S or R1441C mutations were observed [217].